JP2022549833A5 - - Google Patents
Info
- Publication number
- JP2022549833A5 JP2022549833A5 JP2022518762A JP2022518762A JP2022549833A5 JP 2022549833 A5 JP2022549833 A5 JP 2022549833A5 JP 2022518762 A JP2022518762 A JP 2022518762A JP 2022518762 A JP2022518762 A JP 2022518762A JP 2022549833 A5 JP2022549833 A5 JP 2022549833A5
- Authority
- JP
- Japan
- Prior art keywords
- approximately
- formulation according
- denatonium
- salt
- oral formulation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962905943P | 2019-09-25 | 2019-09-25 | |
| US62/905,943 | 2019-09-25 | ||
| PCT/US2020/052588 WO2021062061A1 (en) | 2019-09-25 | 2020-09-24 | Oral pharmaceutical immediate release composition and method of treatment for weight loss |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2022549833A JP2022549833A (ja) | 2022-11-29 |
| JP2022549833A5 true JP2022549833A5 (https=) | 2023-10-02 |
| JP7680762B2 JP7680762B2 (ja) | 2025-05-21 |
Family
ID=75167128
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022518762A Active JP7680762B2 (ja) | 2019-09-25 | 2020-09-24 | 経口速放出性医薬組成物および減量治療の方法 |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US20220280457A1 (https=) |
| EP (1) | EP4034082A4 (https=) |
| JP (1) | JP7680762B2 (https=) |
| KR (1) | KR20220106960A (https=) |
| CN (2) | CN114786647B (https=) |
| AU (1) | AU2020354634A1 (https=) |
| CA (1) | CA3151431A1 (https=) |
| WO (1) | WO2021062061A1 (https=) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA3215858A1 (en) * | 2021-04-27 | 2022-11-03 | Zhenhuan ZHENG | Combination of bitter receptor agonist and gut-signaling compound |
| WO2023064480A1 (en) | 2021-10-14 | 2023-04-20 | Aardvark Therapeutics Inc. | Monohydrate salt of denatonium acetate |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20030068276A1 (en) | 2001-09-17 | 2003-04-10 | Lyn Hughes | Dosage forms |
| US20030198666A1 (en) * | 2002-01-07 | 2003-10-23 | Richat Abbas | Oral insulin therapy |
| KR20040063616A (ko) * | 2003-01-08 | 2004-07-14 | 김원호 | 다이어트 식품용 조제 |
| EP1991054A4 (en) * | 2005-11-10 | 2012-04-25 | Univ Minnesota | SYSTEMIC PLANT STRENGTHENER |
| PL3692983T3 (pl) | 2008-05-15 | 2021-12-27 | Celgene Corporation | Doustne formulacje analogów cytydyny i sposoby ich zastosowania |
| US8357398B2 (en) * | 2009-10-21 | 2013-01-22 | Alitair Pharmaceuticals Inc. | Benzonatate compositions and methods of use |
| EP2582367A4 (en) * | 2010-06-17 | 2013-11-27 | California Inst Of Techn | METHOD AND SYSTEM FOR MODULATING HORMONES AND RELATED METHODS, ACTIVE SUBSTANCES AND COMPOSITIONS |
| EP2661266B1 (en) * | 2011-01-07 | 2020-09-16 | Anji Pharma (US) LLC | Chemosensory receptor ligand-based therapies |
| EP3138900A1 (en) * | 2015-09-04 | 2017-03-08 | The Procter and Gamble Company | Detergent compositions and wrapping films therefor having at least two different aversive agents and methods related thereto |
| EP3138897A1 (en) * | 2015-09-04 | 2017-03-08 | The Procter and Gamble Company | Films at least 80 microns thick comprising aversive agents, unit dose detergent articles wrapped therein, uses and methods related thereto |
| EP3138898A1 (en) * | 2015-09-04 | 2017-03-08 | The Procter and Gamble Company | Water-soluble detergent articles wrapped in a film with an aversive agent mainly in the flanges or skirt thereof |
| US10835505B2 (en) | 2018-06-11 | 2020-11-17 | Aardvark Therapeutics, Inc. | Oral pharmaceutical formulation for weight loss, diabetes and related disorders |
| US12201593B2 (en) | 2018-07-02 | 2025-01-21 | Aardvark Therapeutics Inc. | Oral pharmaceutical formulations of bitter compounds for asthma |
| WO2020014494A1 (en) * | 2018-07-11 | 2020-01-16 | Aardvark Therapeutics Inc. | Oral pharmaceutical formulations of bitter compounds for pulmonary hypertension |
| EP4081201A4 (en) * | 2019-12-24 | 2024-01-10 | Aardvark Therapeutics Inc. | Pharmaceutical composition for treatment or prevention of multiple inflammatory disorders |
-
2020
- 2020-09-24 EP EP20868217.9A patent/EP4034082A4/en active Pending
- 2020-09-24 WO PCT/US2020/052588 patent/WO2021062061A1/en not_active Ceased
- 2020-09-24 CN CN202080066539.0A patent/CN114786647B/zh active Active
- 2020-09-24 CN CN202510488506.XA patent/CN120420287A/zh active Pending
- 2020-09-24 JP JP2022518762A patent/JP7680762B2/ja active Active
- 2020-09-24 CA CA3151431A patent/CA3151431A1/en active Pending
- 2020-09-24 KR KR1020227013390A patent/KR20220106960A/ko active Pending
- 2020-09-24 AU AU2020354634A patent/AU2020354634A1/en active Pending
-
2022
- 2022-03-23 US US17/702,452 patent/US20220280457A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP5671560B2 (ja) | 固体投与形中のテトラサイクリン金属錯体 | |
| CN109890391B (zh) | 痴呆症的治疗 | |
| AU2011290614B2 (en) | Nalbuphine-based formulations and uses thereof | |
| NO175131B (no) | Fremgangsmåte for fremstilling av et harpiksadsorbat av ranitidin | |
| KR20090034372A (ko) | 옥시코돈을 포함하는 과립 및 경구 붕해 정제 | |
| KR20090038447A (ko) | 다층 경구 붕해 정제 | |
| CN104114151A (zh) | 用于含有烟碱的治疗组合物的赋形剂 | |
| JP2013528588A (ja) | ニコチン含有医薬組成物 | |
| EP3287438A1 (en) | Choline salt of an anti-inflammatory substituted cyclobutenedione compound | |
| JP7846211B2 (ja) | 治療適用のためのｄ－リゼルグ酸ジエチルアミドの即時放出製剤 | |
| US20120196917A1 (en) | Antidepressant Oral Liquid Compositions | |
| CZ299595B6 (cs) | Farmaceutický prípravek a lécivo pro empirickou lécbu infekcí | |
| KR102479497B1 (ko) | 바레니클린 서방성 제제 및 이의 제조 방법 | |
| US9034382B2 (en) | Oseltamivir phosphate granule and preparation method thereof | |
| WO2004066998A1 (ja) | 安定な経口用固形医薬組成物 | |
| JP2022549833A5 (https=) | ||
| GB2170709A (en) | Pharmaceutical compositions with analgesic properties and the preparation and use thereof | |
| US20080125453A1 (en) | Phenylephrine tannate, pyrilamine tannate and dextromethorphan tannate salts in pharmaceutical compositions | |
| CN101129351A (zh) | 一种补铁剂组合物,其制备方法和应用 | |
| RU2240784C1 (ru) | Лекарственное средство на основе арбидола | |
| KR20220106960A (ko) | 경구 제약 즉시 방출 조성물 및 체중 감량을 위한 치료 방법 | |
| JP2020073583A (ja) | ミューオピオイド受容体アンタゴニストとオピオイド剤との組み合わせ剤形 | |
| EP3968955A1 (en) | Pharmaceutical oral liquid solution of ivacaftor | |
| JP2022536669A5 (https=) | ||
| GB2083749A (en) | Drug combination comprising ambroxol and an antibiotic for the treatment of infectious diseases of the respiratory tract |